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ABSTRACT Epidemiological evidence correlates low serum vitamin A (retinol) levels
with increased susceptibility to active tuberculosis (TB); however, retinol is biologi-
cally inactive and must be converted into its bioactive form, all-trans retinoic acid
(ATRA). Given that ATRA triggers a Niemann-Pick type C2 (NPC2)-dependent antimi-
crobial response against Mycobacterium tuberculosis, we investigated the mechanism
by which the immune system converts retinol into ATRA at the site of infection.
We demonstrate that granulocyte-macrophage colony-stimulating factor (GM-CSF)-
derived dendritic cells (DCs), but not macrophages, express enzymes in the vitamin A
metabolic pathway, including aldehyde dehydrogenase 1 family, member a2 (ALDH1A2)
and short-chain dehydrogenase/reductase family, member 9 (DHRS9), enzymes
capable of the two-step conversion of retinol into ATRA, which is subsequently
released from the cell. Additionally, mRNA and protein expression levels of
ALDH1A2 and DC marker CD1B were lower in tuberculosis lung tissues than in
normal lung. The conditioned medium from DCs cultured with retinol stimulated
antimicrobial activity from M. tuberculosis-infected macrophages, as well as the
expression of NPC2 in monocytes, which was blocked by speciﬁc inhibitors, includ-
ing retinoic acid receptor inhibitor (RARi) or N,N-diethylaminobenzaldehyde (DEAB),
an ALDH1A2 inhibitor. These results indicate that metabolism of vitamin A by DCs
transactivates macrophage antimicrobial responses.
IMPORTANCE Tuberculosis (TB) is the leading cause of death by a single infectious
agent worldwide. One factor that contributes to the success of the microbe is the
deﬁciency in immunomodulatory nutrients, such as vitamin A (retinol), which are
prevalent in areas where TB is endemic. Clinical trials show that restoration of sys-
temic retinol levels in active TB patients is ineffective in mitigating the disease; how-
ever, laboratory studies demonstrate that activation of the vitamin A pathway in My-
cobacterium tuberculosis-infected macrophages triggers an antimicrobial response.
Therefore, the goal of this study was to determine the link between host retinol lev-
els and retinoic acid-mediated antimicrobial responses against M. tuberculosis. By
combining established in vitro models with in situ studies of lung tissue from TB pa-
tients, this study demonstrates that the innate immune system utilizes transcellular
metabolism leading to activation between dendritic cells and macrophages as a
means to combat the pathogen.
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Globally, there are 1.7 billion people infected with Mycobacterium tuberculosis, theetiological agent of tuberculosis (TB), of which, approximately 10% will develop
the active disease and the rest will remain latently infected (1). The incidence of TB is
prominent in low-income areas where people can also suffer from malnutrition, result-
ing in lower systemic levels of immunomodulatory vitamins. Epidemiological studies
have correlated low serum levels of retinol, the circulating form of vitamin A, with a
10-fold increased risk and susceptibility to TB (2–4). In addition, in vitro studies have
demonstrated that stimulation of M. tuberculosis-infected macrophages with all-trans
retinoic acid (ATRA), the bioactive hormonal form of vitamin A, induced antimicrobial
activity against the pathogen (5–8). Collectively, these studies indicate an important
role for the vitamin A system in the immune response against M. tuberculosis infection.
However, for systemic retinol to inﬂuence immune responses at the site of infection, it
must ﬁrst be metabolized into ATRA.
We and others previously showed that treatment of M. tuberculosis-infected mac-
rophages with ATRA results in antimicrobial activity (5, 7, 8). Our study demonstrated
that at least one of the mechanisms driving the ATRA-triggered antimicrobial activity is
the expression of the lipid transporter protein Niemann-Pick type C2 (NPC2), which
mediated both reduction in cellular cholesterol and antimicrobial activity (8). Other
studies have demonstrated the ability of ATRA to restrict infection as well as reduce
survival of M. tuberculosis in macrophages by downregulating the expression of
tryptophan-aspartate containing coat protein (TACO), a cytoskeletal protein that pre-
vents phagosome-lysosome fusion (9). This ability of ATRA to induce these antimicro-
bial mechanisms suggests that the generation of ATRA from retinol may be an
important factor in host defense against M. tuberculosis infection.
For in vivo synthesis of ATRA, retinol is ﬁrst converted into all-trans retinaldehyde
(ATRH), a step catalyzed by several enzymes, including short-chain dehydrogenase/
reductase family, member 9 (DHRS9), DHRS3, and retinol dehydrogenase 10 (RDH10)
(10). ATRH is then converted into ATRA, which can be catalyzed by the aldehyde
dehydrogenase 1 (ALHD1) family of enzymes, including ALDH1A1, ALDH1A2, and
ALHD1A3 (11). Several of these enzymes are expressed in dendritic cells (DCs), an innate
immune cell type which functions as an antigen presentation cell to activate adaptive
immune cells and, importantly, is correlated to host immune control of mycobacterial
infection (12–19). Although resident DCs exist in normal healthy lung, whether the
immune microenvironment in the lung of a TB patient includes DCs or the vitamin A
metabolic system is unclear. Therefore, we investigated the potential of innate immune
cells to metabolize and activate retinol to elicit vitamin A-driven antimicrobial re-
sponses.
RESULTS
Activation of innate immune cells by vitamin A metabolites. To determine if
retinol or other vitamin A metabolites can directly stimulate monocytes, we stimulated
primary human monocytes with equimolar concentrations (108 M) of retinol, all-trans
retinaldehyde (ATRH), or all-trans retinoic acid (ATRA) for 18 h. Following incubation,
total RNA was harvested, and mRNA expression levels of two ATRA response genes,
NPC2 and CYP27A1 (8), were measured by real-time semiquantitative PCR (qPCR). Only
ATRA stimulation resulted in signiﬁcant induction of NPC2 mRNA (Fig. 1A), which is a
required gene for ATRA-induced antimicrobial activity against M. tuberculosis (8).
Similarly, CYP27A1 mRNA expression was signiﬁcantly induced by ATRA but not by
ATRH or retinol (Fig. 1B). However, previous studies have indicated and we conﬁrm here
using samples from our completed studies (20, 21) that serum retinol levels were
signiﬁcantly lower in active tuberculosis patients than in healthy household contacts
(Fig. 1C). It is then unclear how retinol levels inﬂuence tuberculosis pathology; there-
fore, we hypothesize that local metabolism of retinol into ATRA at the site of infection
by immune cells will be crucial to vitamin A-driven host defense.
GM-DCs express the retinol metabolism pathway. Since fetal calf serum (FCS)
used for cell culture typically contains relatively high levels (128 ng/ml) of retinol (22),
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immune cells cultured in FCS that metabolize retinol to ATRA will subsequently
demonstrate an autocrine activation of the retinoic acid receptor (RAR) gene program.
Therefore, we sought to interrogate the gene expression proﬁles of human monocyte-
derived macrophages (MDMs) and DCs for a RAR activation signature. Gene signatures
of macrophages were determined from our previously published gene microarrays of
primary human monocytes stimulated with cytokines that drive macrophage differen-
tiation and polarization (17): interleukin 10 (IL-10; M2a), IL-15 (M1), and IL-4 (M2a). A
signature for DCs was determined from a new gene microarray experiment data set of
primary human monocytes stimulated with the DC differentiation driving cytokine,
granulocyte-macrophage colony-stimulating factor (GM-CSF). Next, Ingenuity Pathway
Analysis (IPA) demonstrated that the DC gene signature, but none of the macrophage
signatures, had signiﬁcant enrichment of the canonical pathway “RAR activation” in the
GM-CSF-induced gene proﬁle (see Fig. S1 in the supplemental material).
The retinol metabolism pathway was further elaborated in the DC proﬁle at a single
gene level, and the mRNA expression of enzymes that metabolize retinol into ATRH
(DHSR3, DHRS9, and RDH10) as well as ATRH into ATRA (ALDH1A1, ALDH1A2, and
ALDH1A3) were examined. For the enzymes that metabolize retinol into ATRH, DHSR9
was signiﬁcantly induced by GM-CSF; however, DHSR3 and RDH10 did not show any
signiﬁcant regulation by GM-CSF (Fig. 2A). As for the enzymes that metabolize ATRH
into ATRA, one of two ALDH1A2 probe sets present on the array was signiﬁcantly
upregulated, ALDH1A1 was signiﬁcantly downregulated, and ALDH1A3 showed no
signiﬁcant regulation by GM-CSF (Fig. 2A). Since both ALDH1A2 probe sets share
probes derived from multiple transcripts according to the manufacturer, we designed
ALHD1A2-speciﬁc primers to conﬁrm the microarray results. Primary human monocytes
were isolated from whole blood and stimulated for 24 h with a titration of GM-CSF (0
ng/ml, 1 ng/ml, 10 ng/ml, or 100 ng/ml) compared to a titration of IL-15 (40 ng/ml, 80
FIG 1 Activation of innate immune cells by vitamin A metabolites. Primary human monocytes were
treated with either vehicle alone (CTRL), retinol (108 M), retinaldehyde (ATRH) (108 M), or all-trans
retinoic acid (ATRA) (108 M) for 18 h and the mRNA expression levels of NPC2 (A) and CYP27A1 (B) were
measured via qPCR. Data shown are the average fold change (FC) versus CTRL  standard error of the
mean (SEM) (n 3 to 7). P values by one-way ANOVA. *, P  0.05; ***, P  0.001. (C) Black dots represent
the serum retinol levels of TB household contact (TB contacts) or active TB patients. The red line indicates
the average  SEM retinol serum levels in each group. P value by Student’s t test. ***, P  0.001.
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ng/ml). Induction of the DC phenotype by GM-CSF was conﬁrmed by the coexpression
and increase in cell surface expression of DC-speciﬁc markers (23), CD206, CD86, and
CD1B measured via ﬂow cytometry (see Fig. S2). The cells were stimulated with IL-15 as
a control given that the IPA did not identify an RAR activation signal by IL-15 (Fig. S1),
but is known to induce vitamin D metabolism in human monocytes (23). Following the
incubation, total RNA was isolated and the expression of DHRS9 and ALDH1A2 was
measured by qPCR. GM-CSF at concentrations of 1 ng/ml, 10 ng/ml, and 100 ng/ml
induced DHRS9 mRNA levels by 9.43-, 16.8-, and 16.3-fold, respectively, compared to
that in an unstimulated control (Fig. 2B). In the same experiment, 1 ng/ml, 10 ng/ml,
and 100 ng/ml of GM-CSF induced ALDH1A2 mRNA levels to 22.0-, 21.9-, and 57.4-fold,
respectively, compared to that in the unstimulated control (Fig. 2C). Since IL-15 did not
induce expression of DHRS9 or ALDH1A2, we assayed CYP27B1 levels to verify that the
IL-15 was active, ﬁnding that IL-15 induced signiﬁcant CYP27B1 expression (Fig. 2D) as
previously described (23). Concurrent induction of DHRS9 and ALDH1A2 by GM-CSF
suggests that the capacity to metabolize retinol into ATRA is part of the GM-CSF-
derived DC gene program.
Transcriptional proﬁling of retinol metabolism in TB infected lung. To establish
the in vivo relevance of vitamin A metabolism and DCs in TB, we extended our
previously published analysis of microarray data, comparing the gene expression
proﬁle of human caseous TB lung tissue to that of unaffected lung (24). The expanded
analysis indicates that the expression of ALDH1A2 and DHRS9, as well as the DC marker
FIG 2 Expression of the retinol metabolic pathway in DCs. (A) Primary human monocytes were
stimulated with GM-CSF for 0, 3, and 12 h, and then gene expression was proﬁled using microarrays.
Expression data of vitamin A pathway genes, DHRS3, DHRS9, RDH10, ALDH1A1, ALDH1A2, and ALDH1A3,
are displayed as mean expression in arbitrary units (AU) from three independent donors  SEM. Primary
human monocytes stimulated with a titration of GM-CSF or IL-15 for 18 h and mRNA expression of DHRS9
(n 3 to 5) (B) and ALDH1A2 (n 3 to 6) (C) were measured by qPCR. Data shown are the average fold
change (FC) versus CTRL  SEM. (D) Induction of CYP27B1 mRNA expression in monocytes by IL-15 was
measured by qPCR. Data shown are the average fold change (FC) versus CTRL  SEM (n 3). P values
by one-way ANOVA. *, P  0.05; **, P  0.01; ***, P  0.001.
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CD1B, was signiﬁcantly less in TB than in unaffected lung tissue (Fig. 3A). In contrast, the
M2 macrophage marker, CD163, was more highly expressed in TB tissue than in
unaffected lung (25). These results suggest a lack of a signiﬁcant vitamin A metabolic
gene proﬁle in the chronic and late state of TB disease. To investigate the early stages
of infection, we utilized a previously published expression data set comparing rabbit
lung after M. tuberculosis infection to uninfected lung tissue (26). This analysis indicates
that ALDH1A2 is signiﬁcantly downregulated after 2 weeks of infection but shows no
change after 16 weeks (Fig. 3B). DHRS9 was signiﬁcantly upregulated at 2 weeks, shown
by one of two probes present on the array, but no signiﬁcant change was detected
otherwise (Fig. 3B). NPC2 was signiﬁcantly downregulated at both 2 and 16 weeks,
whereas CYP27A1 was signiﬁcantly downregulated only at 16 weeks (Fig. 3B). CD1B was
signiﬁcantly upregulated at 2 weeks but signiﬁcantly downregulated at 16 weeks
(Fig. 3B). Lastly, CD163 was signiﬁcantly upregulated at both 2 and 16 weeks (Fig. 3B).
Taken together, with the caveat that the human and rabbit disease pathologies are
likely different (27), these data suggest DCs and the vitamin A metabolic pathway are
downregulated or absent during the course of tuberculosis infection.
DCs and retinol metabolism are absent in TB lung. To conﬁrm the microarray
ﬁndings, surgically resected lung tissue from ﬁve active TB patients were compared to
unaffected lung tissue from non-small lung cancer patients obtained by the UCLA
Translational Pathology Core Laboratory (TPCL) using immunohistochemistry (IHC). The
lung tissues were formalin ﬁxed, parafﬁn embedded, cut into sections, and mounted
onto slides. All TB patient lung sections showed large central caseous necrosis areas
surrounded by largely disorganized cellular regions. Within the cellular regions, lung
sections from two TB patients (TB1 and TB2) showed little to no ALDH1A2 protein
expression, whereas normal lung tissue showed positive cells dispersed throughout the
tissue in clusters (Fig. 4A). In terms of cellular composition, both TB and normal lung
tissues contained macrophages as detected by CD163 expression (Fig. 4B), but the DC
marker, CD1B, was found in the normal lung at higher levels than in TB lung (Fig. 4C).
In the normal lung sections, CD163 cells resided predominately in the alveolar space
and the border of the interstitium, whereas CD1B and ALHD1A2 cells were more
restricted to the interstitium and endothelium, which is where lung DCs are typically
FIG 3 Transcriptional proﬁling of retinol metabolism in TB infected lung. Expression of vitamin A metabolism
(ALDH1A2 and DHRS9) and activation (NPC2 and CYP27A1) genes as well as DC (CD1B) and macrophage (CD163)
markers in human caseous TB versus normal lung tissue (A) and rabbit lung 2 and 16 weeks after M. tuberculosis
infection (B) as measured by gene microarray. P values by one-way ANOVA. *, P  0.05; **, P  0.01; ***, P  0.001.
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found (28). Corresponding isotype control antibodies for ALDH1A2, CD163, and CD1B
show that IHC staining is speciﬁc with limited background signal (Fig. S3). Using
Immunoratio, we quantiﬁed the number of ALDH1A2-, CD163-, and CD1B-positive cells
compared to nuclear staining in 4 to 5 sections per normal lung and 8 to 10 sections
per TB lung. The decreased mRNA expression levels of ALDH1A2 in TB lung from the
microarray data correlated with the decreased protein expression of ALDH1A2 in TB
lung relative to normal lung (Fig. 4D). In contrast, we found that TB lung expressed
signiﬁcantly higher CD163 protein levels relative to normal lung (Fig. 4E). Lastly, the
decreased CD1B mRNA expression in TB lung also correlated with the decreased
protein expression of CD1B in TB lung relative to normal lung (Fig. 4F). Taken together,
the decrease in ALDH1A2 and CD1B in the TB lung indicates that genes in the vitamin
A metabolic pathway and a DC-speciﬁc cell surface marker are signiﬁcantly lower in TB
lung.
FIG 4 CD1B and ALDH1A2 expression in TB lung. TB patient lung and normal lung tissue protein
expression of ALDH1A2 (A), CD163 (B), and CD1B (C) by immunohistochemistry. Data shown are
representative images (TB lung [TB], n 8 to 10; normal lung [NL], n 4 to 5). Scale bar, 40 m.
Expression of ALDH1A2 (D), CD163 (E), and CD1B (F) in TB versus normal lung was quantiﬁed per
nucleated cell using Immunoratio. Data shown are the average percentage of positive cells/nucleus 
SEM. P value by Student’s t test. *, P  0.05; ***, P  0.001.
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GM-DCs demonstrate metabolism of retinol to ATRA. For DCs to play a vitamin
A-dependent immunomodulatory role in TB, they have to functionally metabolize
retinol into ATRA and transactivate infected cells. To establish that the induction of
DHRS9 and ALDH1A2 in GM-CSF-derived DCs led to the two-step bioconversion of
retinol into ATRA, GM-CSF-derived DCs were cultured under serum-free conditions with
or without exogenous retinol for 6 h, and retinol metabolites were measured in the
cellular and supernatant fractions via high-performance liquid chromatography (HPLC).
The total levels of ATRA were measured from the cellular fraction of DCs incubated with
control, 1 ng/ml, or 10 ng/ml of retinol at an average of 9.8, 150.4, and 121.0 mean
arbitrary units (mAU), respectively (Fig. 5A). From the same experiments, the ATRA
contained in the supernatants from DCs incubated with control, 1 ng/ml, or 10 ng/ml
of retinol was quantiﬁed at 16.6, 251.2, and 2131.2 mAU, respectively, which at the
10 ng/ml concentration, was signiﬁcantly (17.6-fold) higher than in the cellular fraction.
FIG 5 Activation of monocytes and macrophages with DC-produced ATRA. (A) GM-CSF-derived DCs
were treated with the indicated amounts of retinol for 6 h under serum-free conditions, and the amounts
of ATRA in the cellular (Cell) and supernatant (Supe) fractions were analyzed via HPLC. Data represent the
means  SEMs of the average area of ATRA peak from HPLC plots (n 4). Data shown are the average
fold change versus control  SEM (n 3 to 7). P values by one-way ANOVA. *, P  0.05; ***, P  0.001.
Expression levels of NPC2 (B) and CYP27A1 (C) were measured by qPCR in primary human monocytes
cultured with CM from DCs with or without retinol. From the same experiments, expression levels of
NPC2 (D) and CYP27A1 (E) were measured in primary human monocytes cultured with CM from DCs
pretreated with DEAB for 20 min prior to addition of retinol. Primary human monocytes were also
pretreated with RARi and treated with CM from DC with or without retinol, and mRNA expression levels
of NPC2 (F) and CYP27A1 (G) were measured by qPCR. All experimental conditions (panels B to G) were
performed in parallel. Data shown are the average fold change versus control  SEM (n 3 to 7).
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These data indicate that providing retinol to GM-CSF-derived DCs results in the
production of ATRA, which can be found in both the cellular and extracellular fractions,
with the majority of ATRA present extracellularly.
DC-produced ATRA transactivates RAR in monocytes. To ascertain if the extra-
cellular ATRA produced by DCs can transactivate other immune cells, DCs were cultured
for 18 h under serum-free conditions with or without exogenous retinol, and the
conditioned medium (CM) supernatants were collected and supplemented with FCS.
The supplemented CM was used to culture fresh primary human monocytes for 18 h,
and gene expression of NPC2 and CYP27A1 was assessed using qPCR. Incubation of
monocytes with the DC CM containing exogenous retinol induced a signiﬁcant 3.8-fold
expression of NPC2 (Fig. 5B) and a 3.3-fold expression of CYP27A1 compared to that in
CM with no retinol (Fig. 5C). In the same experiments, we also utilized N,N-
diethylaminobenzaldehyde (DEAB) and BMS 493 (RARi), inhibitors of ALDH1A2 and
RAR, respectively, to address the role of vitamin A metabolism and RAR activation in the
ability of CM to induce NPC2 and CYP27A1.
Concurrent treatment of the DCs with DEAB during incubation with exogenously
added retinol during generation of CM inhibited the ability of the resulting CM to
induce NPC2 (Fig. 5D) and CYP27A1 in monocytes (Fig. 5E); however, DEAB had no
direct effect on ATRA induction of NPC2 and CYP27A1 (see Fig. S4A). Furthermore,
20-min pretreatment of monocytes with RARi prior to addition of the FCS-
supplemented CM also inhibited induction of NPC2 (Fig. 5F) and CYP27A1 (Fig. 5G). In
separate experiments, the RARi inhibited ATRA-induced expression of NPC2 and
CYP27A1 in primary human monocytes at a 10-fold excess (Fig. S4B). Taken together,
these results indicate that DCs are able to produce ATRA, in part through ALDH1A2
activity, from exogenous retinol and stimulate RAR-induced gene expression in neigh-
boring cells.
DC-produced ATRA induces antimicrobial activity in M. tuberculosis-infected
MDMs. To determine whether DC-produced ATRA can transactivate innate immune
cells to trigger antimicrobial activity, medium was supplemented with or without
exogenous retinol (10 ng/ml) and was conditioned by DCs for 18 h. Macrophages were
derived from primary human monocytes using M-CSF (MDMs), as we previously de-
scribed (29), and infected with H37Rv for 18 h. Following the infection, extracellular
bacterium was removed through extensive washing, and the infected MDMs were
recultured with FCS-supplemented CM. Bacterial viability was assessed after 72 h using
our previously described PCR-based method (8). When the infected MDMs were
cultured using CM with exogenous retinol, the resulting bacterial viability was signiﬁ-
cantly lower than for cells cultured with CM with no retinol (Fig. 5H). These data suggest
that DCs are capable of triggering a retinol-dependent antimicrobial response in trans.
DISCUSSION
Vitamin A metabolites have been implicated in the pathogenesis of TB in humans.
Low levels of the circulating form of vitamin A, retinol, correlate with susceptibility to
disease (3, 4, 28), whereas the bioactive form of vitamin A, ATRA, induces antimicrobial
activity in M. tuberculosis-infected macrophages (5, 7–9). Given that retinol is biologi-
cally inactive, our work sought to explore the mechanism by which retinol can inﬂuence
the immune response, speciﬁcally, to understand how retinol is metabolized into a
bioactive form by immune cells. A bioinformatics survey of primary human monocyte
gene expression proﬁles elicited by macrophage- and DC-differentiating cytokines
indicated that the DC-differentiating cytokine, GM-CSF, induces expression of genes
encoding enzymes in the vitamin A metabolic pathway, DHRS9 and ALDH1A2. Exam-
ining human and rabbit TB lung in situ, we found that expression of vitamin A
metabolism genes and the DC marker CD1B were largely downregulated in lung tissue
from TB patients compared to that in controls. GM-CSF-derived DCs, by producing
ATRA from retinol and releasing it, can elicit a response in trans to neighboring
monocytes/macrophages, including induction of NPC2 and an antimicrobial response.
Taken together, the present results indicate that DCs, through metabolism of retinol,
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may play a critical role supplying a bioactive form of vitamin A to neighboring infected
macrophages, eliciting antimicrobial responses in TB.
Previous studies have correlated vitamin A deﬁciency to TB, including populations
with a high incidence of TB, such as South Korea (30), India (31), and Indonesia (32).
Another multinational study also demonstrated signiﬁcant association of retinol deﬁ-
ciency with TB in HIV-positive patients (33). Our study examined a multiethnic popu-
lation in the United Kingdom, which has an overall low incidence of TB and malnutri-
tion (20, 21). The fact that vitamin A deﬁciency signiﬁcantly correlated with TB
compared to healthy household contacts in our population suggests that retinol plays
an important role in TB pathogenesis and may not simply be coincident to malnour-
ishment in impoverished countries with endemic M. tuberculosis or with HIV coinfec-
tion. Thus, how retinol is metabolized into the active hormone, ATRA, by the immune
system to elicit antimicrobial responses will be an important factor to host defense
against M. tuberculosis infection.
The canonical function of DCs is to regulate the adaptive immune response
through antigen presentation and cytokine secretion; our results indicate that DCs
can also regulate the immune response through metabolic activity. Here, we
provide evidence that metabolism of vitamin A by DC leads to the release of ATRA,
which can subsequently transactivate RAR in neighboring monocytes/macro-
phages. Transcellular metabolism was previously described for the production of
eicosanoids from arachidonic acid, where prostaglandins are metabolized by one
cell and then the biosynthetic intermediates are delivered to monocytes and
macrophages to be further metabolized (34, 35). In contrast, our results provide
evidence that the metabolism of retinol into ATRA by DCs led to transactivation of
macrophages, resulting in antimicrobial activity against M. tuberculosis. There is
increasing evidence that nuclear hormones such as vitamin A and vitamin D play an
integral role in innate immune response, and while both require a metabolic step
converting the inactive substrate into the active hormone, it is unclear if vitamin D
metabolism results in transcellular activation (36).
The role of DCs in TB pathogenesis is not well deﬁned due to the lack of an
accessible experimental animal system that accurately models the human disease as
well as to the difﬁculty in acquiring lung tissue samples from active and latent TB
patients. Many of the immune paradigms described for the host immune response to
mycobacterial infections have, therefore, been established by studying other human
mycobacterial diseases, especially leprosy, which is caused by dermal infection with
Mycobacterium leprae. CD1B DCs were found in the granulomas derived from patients
with the self-limiting form of leprosy (tuberculoid); in contrast, DCs were absent in the
lesions derived from patients with the disseminated form of leprosy (lepromatous) (37).
Examination of resected lung tissue from patients with active TB conﬁrmed similar
results, since both gene and protein expression of the DC speciﬁc marker, CD1B, as well
as ALDH1A2 are signiﬁcantly diminished in TB lung relative to that in normal lung,
accompanied by an increase in CD163 expression (25). Although CD163 is predomi-
nantly expressed by macrophages, a subset of tolerogenic IL-10-secreting DCs express-
ing cell surface CD163 have been described (38). The presence of IL-10-secreting
tolerogenic DCs would correlate with the permissive immune microenvironment of
both lepromatous leprosy and tuberculosis and warrants further investigation of their
role in disease pathogenesis (39, 40).
Since patient-derived TB lung samples represent a late stage of disease, we utilized
data from experimental animal studies to understand the regulation of DCs and vitamin
A metabolism at the onset of infection in rabbits. Based on our gene expression analysis
of rabbit lung, while there was an increase in CD1B expression at the onset of M.
tuberculosis infection, the levels dropped as the infection progressed. Other studies
have shown a similar pattern in the mouse lung during M. tuberculosis infection, where
DCs drain to the nearest lymph node and have impaired function (41). However, the
mechanism leading to the decrease in CD1B and ALDH1A2 in human TB lung is unclear
given M. tuberculosis infection has been described to result in DC cell death (42),
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transmigration away from the lung (43), and defective DC differentiation (44). Our
previous study indicates that ATRA stimulation does not induce CD1B expression (45),
but we cannot rule out that ATRA might result in the downregulation of CD1B on the
cell surface of DCs. However, given that TB patients are likely to be systemically retinol
deﬁcient and possibility ALDH1A2 deﬁcient at the site of infection, it is unlikely there
will be abundant ATRA present. Since the presence of DCs and likely their ability to
function properly correlates with favorable outcome to disease, factors that regulate
DCs during infection in the complex microenvironment of granulomas will warrant
further investigation. Although at this time, we cannot differentiate if DCs in the TB
lung have downregulated expression of CD1B and ALDH1A2 but are still present nor
rule out the presence of DCs with low CD1B and ALDH1A2 expression.
We demonstrate here that generation of ATRA by DCs can transactivate infected
macrophages to elicit antimicrobial activity. However, due to the pleiotropic effects of
ATRA on the immune system, the effects of ATRA transactivation are not limited to
induction of NPC2, and include other processes critical to host defense against M.
tuberculosis infection, such as (i) autophagy (46), (ii) driving monocyte differentiation
into CD209 macrophages with antimicrobial properties (45), or (iii) macrophages with
tissue-preservation/wound-healing functions (47). ATRA can also regulate the adaptive
immune response through inducing differentiation of Foxp3 regulatory T cells as well
as preserving Th1 inﬂammatory responses (48). Since sustained inﬂammation in the
lung can lead to severe lung tissue damage or mortality, regulation of chronic inﬂam-
mation by FoxP3 regulatory T cells can be important in disease outcome and
reduction of mortality (49). In combination, CD209 macrophages and the Th1 inﬂam-
matory response are critical to the clearance of mycobacterium from the host (29, 50,
51), whereas tissue-like macrophages are critical to sustaining granulomas, thus pre-
venting the spread of disease within the host in vivo (52). Studies have also indicated
that ATRA regulates the composition of the extracellular matrix through induction of a
gene expression proﬁle that drives tissue preservation and wound healing. Active TB
lungs show an increase of MMP-1, MMP-8, and MMP-9 protein expression and a
decrease in TIMP-1 protein expression, which results in pulmonary cavitation (53–55).
In contrast, stimulation of monocytes with ATRA decreases mRNA expression of MMP-
1/MMP-9 and increases the expression of TIMP-1, leading to tissue preservation and
wound healing (47). The diverse roles of ATRA-mediated immunological pathways
suggest that regulating vitamin A metabolism at the site of infection can play a critical
role in balancing the antimicrobial response and mitigate inﬂammation-triggered tissue
damage in TB.
Clinical studies have shown that patients with active TB have lower circulating
retinol levels than healthy individuals (2–4); however, retinol supplementation has
demonstrated mixed results (56–60). Yet, Aibana et al. demonstrated that household
contacts who are vitamin A deﬁcient have a 10-fold increased risk in acquiring tuber-
culosis disease (2), and active TB patients treated with chemotherapy exhibit increased
circulating retinol levels (4). These studies indicate that the vitamin A system plays
an important role in mitigating TB; however, the mechanism by which retinol
inﬂuences the immune response is not a direct effect. Our results here demonstrate
that for retinol to trigger an antimicrobial response, it must ﬁrst be metabolized into
ATRA; therefore, since TB lung has lower expression of ALDH1A2, systemic resto-
ration of retinol levels will have minimal effects at the site of infection with a lack
of local metabolism-dependent transactivation. Therefore, novel therapeutics that
enhance retinol metabolism in the lungs of active TB patients could potentially be
used in conjunction with retinol supplementation as an immunotherapy targeting
the innate immune response to infection. Alternatively, given that normal lung
expresses the vitamin A metabolic machinery, supplementation of retinol-deﬁcient
individuals prior to M. tuberculosis exposure provides a strategy that might prevent
the spread of disease.
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MATERIALS AND METHODS
Statistics. A two-tailed Student’s t test was used to compare two different experimental conditions.
Experiments with three or more measurements were analyzed using one-way analysis of variance
(ANOVA) or Kruskal-Wallis one-way ANOVA on ranks as appropriate with the Student-Newman-Keuls
method for pairwise analyses using GraphPad Prism 7 software. Error bars in ﬁgures represent the
standard errors of the means between individual donor values. The P values are either precisely indicated
in the text or noted in the ﬁgures using the following convention: *, P 0.05; **, P 0.01; ***, P 0.001.
Reagents. Retinol, ATRA, and ATRH were purchased (Sigma-Aldrich), dissolved in dimethyl sulfoxide
(DMSO) and stored at 80°C in small aliquots protected from light. Unless stated, the retinol, ATRH, and
ATRA were utilized at 108 M. Recombinant IL-15 (R&D systems) and GM-CSF (R&D systems) were
cultured with monocytes in RPMI 1640 (Gibco) and 10% fetal calf serum (FCS) (Omega Scientiﬁc).
Monocytes were differentiated into macrophages with macrophage colony-stimulating factor (M-CSF)
(R&D systems) as described as previously (8). Immunohistochemistry was performed with the following
antibodies: puriﬁed-CD1B (MT101; BD biosciences), puriﬁed-ALDH1A2 (ab75674; Abcam), and puriﬁed-
CD163 (EDHu-1; Bio-Rad).
Retinol measurements of clinical samples. Adult TB contacts (n 202) and adult patients with
smear-positive pulmonary TB (n 145) were recruited from TB clinics in London, UK, as previously
described (20, 21). Serum concentrations of retinol were determined by high-performance liquid
chromatography (HPLC) in the clinical biochemistry departments of Northwick Park Hospital (TB con-
tacts) and the Royal London Hospital (TB patients). The studies were approved by the research ethics
committees of North East London, Harrow, and East London and The City Research Ethics Committee
(REC references P/02/146, EC 2759, and 06/Q0605/83), and written informed consent to participate was
obtained from all participants.
Flow cytometry. The following antibodies (BD Biosciences) were used for ﬂow cytometry: CD1B-
ﬂuorescein isothiocyanate (FITC; MT101), CD86-allophycocyanin (APC; FUN-1), and CD206-phycoerythrin
(PE; 19.2). DCs were harvested and subsequently stained as previously described (15).
Quantitative real-time PCR. Gene expression of CYP27B1, CYP27A1, NPC2, DHRS9 and ALDH1A2
were analyzed by real-time semiquantitative PCR (qPCR) as described previously (8). The primers were as
follows: ALDH1A2 Forward, 5=-TTG GTT CAG TGT GGA GAA GG-3=; ALDH1A2 Reverse, 5=-AAA GCT TGC
AGG AAT GGT TTG-3=; DHRS9 Forward, 5=-CTT GCA ATC GTT GGA GGG GGC T-3=; DHRS9 Reverse, 5=-AGA
CAG CTG CTC CCA AAT GGC G-3=. Genes were normalized to 36B4 levels and the threshold cycle (ΔΔCT)
method was used to calculate fold change; 1 mg of RNA was used.
Bioconversion of retinol to all-trans retinoic acid. DCs were differentiated as described above and
treated with or without retinol for 6 h under serum-free conditions. The cultures were harvested, and the
supernatants and cellular fractions were separated by centrifugation (300  g). Retinoids were extracted
in hexane, and samples were analyzed by high-performance liquid chromatography as previously
described (61). ATRA levels are expressed as mean arbitrary units (mAU).
Conditioned medium. DCs were generated from primary human monocytes treated with GM-CSF
for 2 days. The DCs were harvested, washed, enumerated, and a portion was pretreated with DEAB
(STEMCELL Technologies) for 20 min; all the DCs were treated with or without retinol for 18 h at 37°C and
5% CO2. The conditioned medium was harvested, ﬁltered with a 0.2-m ﬁlter, aliquoted, and frozen in
a 80°C freezer. Fresh monocytes were then isolated by plastic adherence, and a portion were
pretreated with BMS493, a pan-RAR inhibitor (RARi) (Tocris), for 20 min at 37°C and 5% CO2; then, 900
l of conditioned medium and 100 l of fresh FCS were added to the culture. The cells were incubated
for 18 h and the gene expression of NPC2 was measured as explained above.
M. tuberculosis and antimicrobial assay. H37rv was cultured, harvested, and enumerated as
previously described (8). Macrophages were isolated as explained above and infected with H37rv for
24 h. Extracellular bacteria were vigorously washed out of the tissue culture well, and the cells were
treated with 90% of conditioned medium and 10% of fresh FCS and incubated for 3 days. The monolayers
were harvested, and bacterial viability was calculated with a PCR-based method as previously described
(8), which compares 16S RNA levels to a genomic DNA (IS6110) levels as an indicator of bacterial viability.
Following the incubation, the cells are harvested and divided. Half of the cells were lysed by boiling at
100°C for 5 min and then snap-frozen at 80°C. Total RNA was isolated from the remaining half using
TRIzol (Life Technologies) according to the manufacturer’s recommended protocol, followed by RNA
cleanup and on-column DNase digestion using an RNeasy Miniprep kit (Qiagen, Valencia, CA). cDNA was
synthesized from the total RNA using the iScript cDNA Synthesis kit (Bio-Rad, Hercules, CA) according to
the manufacturer’s recommended protocol. The bacterial 16S rRNA and genomic element DNA levels
were then assessed from the cDNA and cellular lysate, respectively, by real-time PCR using iQ SYBR green
(Bio-Rad). Comparison of the bacterial DNA to the mammalian genomic 36B4 levels was used to monitor
infectivity between all the conditions in the assay as well as PCR quality. The 16S and DNA values were
calculated using the ΔΔCT analysis, with the mammalian bacterial DNA value serving as the housekeep-
ing gene.
Caseous versus human lung microarray data. For the caseous tuberculosis granuloma, data ﬁles
were obtained from the Gene Expression Omnibus database (https://www.ncbi.nlm.nih.gov/geo/, acces-
sion numbers GSE20050, GSE23073, GSE13762, and GSE28995) (62). Gene expression levels were
normalized to G3PDH. Since there are multiple G3PDH probes represented on the microarray, the NPC2
and IL-6 probe values were normalized to every G3PDH probe and averaged.
Microarray analysis of macrophage and DC proﬁles. Expression proﬁles of IL-10-, IL-15-, and
IL-4-derived macrophages were analyzed from previous data deposited in the Gene Expression Omnibus
database (https://www.ncbi.nlm.nih.gov/geo/) in series entity GSE59184 (17). Brieﬂy, adherent peripheral
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blood mononuclear cells (PBMCs) from four healthy individuals were stimulated with the various
cytokines, and CD14 cells were harvested at 0 h, 6 h, or 24 h after stimulation. RNA expression was
analyzed by Affymetrix Human U133 Plus 2.0 array. DC expression proﬁles were derived from CD14
puriﬁed monocytes from three healthy individuals and then stimulated with recombinant GM-CSF
(100 U/ml) for 0, 3 h, or 12 h. Total RNA was isolated and then processed by the University of California
Los Angeles Clinical Microarray Core Facility using Affymetrix Human U133 Plus 2.0 array and normalized
as previously described (8, 36). Expression gene signatures of DCs and macrophages were determined by
analyzing genes with 1.5-fold change, a P value of 0.05, and experimental minus baseline intensity
of 100 across all time points versus time zero. Gene signatures were then analyzed by Ingenuity
Pathways Analysis (Qiagen) using the canonical pathways comparison function for nuclear receptor
activation. Microarray data from rabbit lung was downloaded from GSE33094 (26). Brieﬂy, New Zealand
White rabbits were infected via aerosol with M. tuberculosis HN878, and total RNA isolated from rabbit
lungs at indicated times. Agilent-020908 Oryctolagus cuniculus two-color Oligo Microarray was utilized
using one channel for infected and the other color channel for uninfected per sample. Gene expression
was represented as the fold-change between M. tuberculosis HN878-infected and uninfected animals at
various times postinfection.
Immunohistochemistry. The tissue sections were deparafﬁnized using xylene washes for 5 min each
followed by three 10-min 100% ethanol washes. After the washes, the slides were placed in a pressure
cooker containing 15 ml of antigen unmasking solution (vector) in 1,600 ml of distilled water at a boil.
The slides were incubated in the pressure cooker at full pressure for 5 min and then placed in
phosphate-buffered saline (PBS) to prevent the tissue from drying. Then, the slides were transferred into
3% H2O2 for 10 min followed by three washes with distilled water. For ALDH1A2, the tissue sections were
blocked with PBS-5% rabbit serum, and for CD1B, PBS-5% goat serum, for 30 min at room temperature;
then, the sections were incubated with the corresponding primary antibody at the manufacturer’s
recommended concentration at 4°C overnight. A biotinylated secondary antibody corresponding to the
species type of the primary antibody was added to the sections following washes for 1 h at room
temperature. The slides were developed with ABC reagent (Vector) for 30 min at room temperature and
then treated with peroxidase solution for 30 min at room temperature. The tissue sections were
counterstained with hematoxylin.
Study approval. This study was conducted according to the principles expressed in the Declaration
of Helsinki and was approved by the Institutional Review Board of the University of California at Los
Angeles. Whole blood from healthy donors was acquired from two sources: (i) through the UCLA CFAR
Virology Core and (ii) UCLA IRB number 92-10-591-31 with informed consent. Peripheral blood mono-
nuclear cells (PBMCs) were isolated from the peripheral blood of healthy donors using a Ficoll-Paque (GE
Health Care) density gradient, and monocytes were puriﬁed by plastic adherence as previously described
(8, 15, 23). Monocyte-derived macrophages (MDMs) and granulocyte-macrophage colony-stimulating
factor (GM-CSF)-derived DCs were produced as previously described (15, 23).
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